Secondly, we observed increased CEBPA binding to the G2DHE in CebpaDM AML compared to normal progenitors and found that deletion or mutagenesis of the CEBPA-bound region of the enhancer resulted in lower expression of Gata2 in CebpaDM cells. The gene discussed is CEBPA; the disease is acute myeloid leukemia.